67Cu SAR 5B1
Alternative Names: [67]CuSAR5B1; [67Cu]Cu-SAR-5B1Latest Information Update: 12 Jul 2024
At a glance
- Originator Clarity Pharmaceuticals
- Class Antibodies; Antineoplastics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Prostate cancer